Healthcare/Biotech Analyst Devarakonda discusses obesity with Veru on an Analyst/Industry conference call to be held on April 16 at 11 am.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERU:
- Veru initiated with an Outperform at Raymond James
- Veru Reschedules Annual Meeting of Shareholders
- Veru appoints Louis Arrone as chief medical advisor for Enobosarm program
- Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
- Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q